Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein ? from hematopoietic cells in a family with AML.
Stelljes M, Corbacioglu A, Schlenk RF, Döhner K, Frühwald MC, Rossig C, Ehlert K, Silling G, Müller-Tidow C, Juergens H, Döhner H, Berdel WE, Kienast J, Koschmieder S
Research article (journal)Details about the publication
Journal: Leukemia
Volume: 25
Issue: 7
Page range: 1209-1210
Status: Published
Release year: 2011
Language in which the publication is written: English
Keywords: Leukemia Myeloid Acute; Female; Recurrence; Anticipation Genetic; Adult; Salvage Therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Neoplastic Syndromes Hereditary; Combined Modality Therapy; Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cells; Neoplasms Second Primary; Transplantation Homologous; Pedigree; Peripheral Blood Stem Cell Transplantation; Germ-Line Mutation; CCAAT-Enhancer-Binding Protein-alpha; Survivors; Humans; Child Preschool; Leukemia Myeloid Acute; Female; Recurrence; Anticipation Genetic; Adult; Salvage Therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Neoplastic Syndromes Hereditary; Combined Modality Therapy; Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cells; Neoplasms Second Primary; Transplantation Homologous; Pedigree; Peripheral Blood Stem Cell Transplantation; Germ-Line Mutation; CCAAT-Enhancer-Binding Protein-alpha; Survivors; Humans; Child Preschool
Authors from the University of Münster
| Frühwald, Michael Christoph | University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO) |